The calm situation in cough, cold and allergy remedies, caused by the absence of any extraordinary epidemics of flu or other viral infections in 2011, was broken by new government initiatives. In April 2011 it was announced that codeine was to be switched to prescription status from May 2011. However, after consideration of the opinions of market players, the start of a ban on OTC sales of codeine-containing drugs was moved to 1 June 2012. The Terpinkod brand fell under this legislation.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Russia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Click for Report details:Cough, Cold and Allergy (Hay Fever) Remedies in Russia - Market Research Report